Edition:
United Kingdom

Endologix Inc (ELGX.OQ)

ELGX.OQ on NASDAQ Stock Exchange Global Select Market

6.59USD
15 Jun 2018
Change (% chg)

$-0.04 (-0.60%)
Prev Close
$6.63
Open
$6.60
Day's High
$6.71
Day's Low
$6.51
Volume
399,395
Avg. Vol
153,967
52-wk High
$6.71
52-wk Low
$3.75

Latest Key Developments (Source: Significant Developments)

Endologix Inc Files For Mixed Shelf Of Upto $100 Million
Thursday, 31 May 2018 

May 31 (Reuters) - Endologix Inc ::ENDOLOGIX INC FILES FOR MIXED SHELF OF UPTO $100 MILLION - SEC FILING.  Full Article

Endologix Q3 loss per share $0.17
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Endologix Inc ::Endologix reports third quarter 2017 financial results.Sees FY 2017 gaap loss per share $0.91 to $0.93.Q3 loss per share $0.17.Sees FY 2017 revenue $181 million to $184 million.Q3 revenue $46 million versus I/B/E/S view $46.7 million.Q3 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S.  Full Article

Endologix says operations not materially affected by Santa Rosa fires‍​
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Endologix Inc : :Comments on impact of the Santa Rosa fires impact on co's facility ‍​.Co's Santa Rosa, California-based facility that manufactures and develops its ovation product line is safe and secure.Says it operations have not been materially affected by the Santa Rosa fires.Endologix Inc says it resumed shipments from its Santa Rosa facility on Oct 10, following a brief delay, and plans to resume manufacturing soon.Endologix Inc says many of the company’s Santa Rosa employees have been adversely impacted by the fire.  Full Article

COLUMBIA WANGER ASSET MANAGEMENT REPORTS 7.6 PCT PASSIVE STAKE IN ENDOLOGIX INC AS OF DEC 31, 2016
Friday, 10 Feb 2017 

Columbia Wanger Asset Management LLC:COLUMBIA WANGER ASSET MANAGEMENT LLC REPORTS 7.6 PERCENT PASSIVE STAKE IN ENDOLOGIX INC AS OF DEC 31, 2016 - SEC FILING.  Full Article

Endologix announces first patients treated with Ovation Alto Abdominal Stent Graft System
Wednesday, 17 Aug 2016 

Endologix Inc : Endologix announces first patients treated with Ovation Alto™ Abdominal Stent Graft System .Ovation alto expected to be introduced into Europe in 2017 and U.S. In 2018.  Full Article

Endologix reports results for the second quarter 2016
Tuesday, 2 Aug 2016 

Endologix Inc : Sees FY 2016 GAAP loss per share $1.80 to $1.85 . Sees FY 2016 revenue $197 million to $203 million . Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S . Endologix reports results for the second quarter 2016 . Q2 loss per share $0.81 . Q2 revenue $51 million versus I/B/E/S view $46.3 million . Sees FY 2016 adjusted non-GAAP loss per share $0.70 to $0.75 .FY2016 earnings per share view $-0.79, revenue view $198.2 million -- Thomson Reuters I/B/E/S.  Full Article

Brown Capital Management LLC reports 5.93 pct passive stake in Endologix - SEC filing
Thursday, 7 Jul 2016 

Brown Capital Management LLC:Brown Capital Management, LLC reports 5.93 percent passive stake in Endologix Inc as of June 30 - SEC filing.  Full Article

BRIEF-Endologix Reports Q1 Loss Per Share $0.24

* Q1 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S